Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Williamson Stephen | Sr. VP and CFO | Aug 15 | Option Exercise | 157.68 | 12,300 | 1,939,464 | 56,244 | Aug 16 05:25 PM | Williamson Stephen | Sr. VP and CFO | Aug 15 | Sale | 603.48 | 12,300 | 7,422,789 | 43,944 | Aug 16 05:25 PM | Williamson Stephen | Sr. VP and CFO | Aug 12 | Option Exercise | 157.68 | 15,000 | 2,365,200 | 58,944 | Aug 16 05:25 PM | Williamson Stephen | Sr. VP and CFO | Aug 12 | Sale | 601.32 | 15,000 | 9,019,813 | 43,944 | Aug 16 05:25 PM | Boxer Michael A | SVP and General Counsel | Aug 08 | Option Exercise | 192.98 | 7,283 | 1,405,473 | 19,681 | Aug 10 04:08 PM | Boxer Michael A | SVP and General Counsel | Aug 08 | Sale | 590.80 | 7,283 | 4,302,796 | 12,398 | Aug 10 04:08 PM | CASPER MARC N | Chairman & CEO | Aug 04 | Option Exercise | 129.77 | 10,000 | 1,297,700 | 193,373 | Aug 05 04:10 PM | CASPER MARC N | Chairman & CEO | Aug 04 | Sale | 589.76 | 10,000 | 5,897,621 | 183,373 | Aug 05 04:10 PM | CASPER MARC N | Chairman & CEO | Aug 03 | Option Exercise | 129.77 | 10,000 | 1,297,700 | 193,373 | Aug 05 04:10 PM | CASPER MARC N | Chairman & CEO | Aug 03 | Sale | 588.28 | 10,000 | 5,882,769 | 183,373 | Aug 05 04:10 PM | CASPER MARC N | Chairman & CEO | Aug 02 | Option Exercise | 129.77 | 10,000 | 1,297,700 | 193,373 | Aug 03 04:33 PM | CASPER MARC N | Chairman & CEO | Aug 02 | Sale | 588.36 | 10,000 | 5,883,584 | 183,373 | Aug 03 04:33 PM | CASPER MARC N | Chairman & CEO | Aug 01 | Option Exercise | 129.77 | 10,000 | 1,297,700 | 193,373 | Aug 03 04:33 PM | CASPER MARC N | Chairman & CEO | Aug 01 | Sale | 592.52 | 10,000 | 5,925,218 | 183,373 | Aug 03 04:33 PM | MANZI JIM P | Director | Aug 01 | Sale | 597.24 | 814 | 486,156 | 15,807 | Aug 03 04:09 PM | Lagarde Michel | Executive Vice President & COO | May 27 | Option Exercise | 354.20 | 13,030 | 4,615,237 | 28,788 | May 31 05:13 PM | Lagarde Michel | Executive Vice President & COO | May 27 | Sale | 565.04 | 13,030 | 7,362,493 | 15,758 | May 31 05:13 PM | Lagarde Michel | Executive Vice President & COO | May 26 | Option Exercise | 238.36 | 16,764 | 3,995,906 | 32,522 | May 31 05:13 PM | Lagarde Michel | Executive Vice President & COO | May 26 | Sale | 536.01 | 16,764 | 8,985,593 | 15,758 | May 31 05:13 PM | Lagarde Michel | Executive Vice President & COO | May 25 | Option Exercise | 238.11 | 5,048 | 1,201,975 | 20,806 | May 25 07:54 PM | Lagarde Michel | Executive Vice President & COO | May 25 | Sale | 542.47 | 5,048 | 2,738,370 | 15,758 | May 25 07:54 PM | Lagarde Michel | Executive Vice President & COO | May 24 | Option Exercise | 204.16 | 17,150 | 3,501,336 | 32,908 | May 25 07:54 PM | Lagarde Michel | Executive Vice President & COO | May 24 | Sale | 548.30 | 17,150 | 9,403,383 | 15,758 | May 25 07:54 PM | CASPER MARC N | Chairman & CEO | May 04 | Option Exercise | 129.77 | 10,000 | 1,297,700 | 193,373 | May 05 06:09 PM | CASPER MARC N | Chairman & CEO | May 04 | Sale | 562.46 | 2,181 | 1,226,730 | 183,373 | May 05 06:10 PM | CASPER MARC N | Chairman & CEO | May 04 | Sale | 548.27 | 7,819 | 4,286,905 | 185,554 | May 05 06:09 PM | CASPER MARC N | Chairman & CEO | May 03 | Option Exercise | 129.77 | 10,000 | 1,297,700 | 193,373 | May 05 06:09 PM | CASPER MARC N | Chairman & CEO | May 03 | Sale | 547.61 | 10,000 | 5,476,103 | 183,373 | May 05 06:09 PM | CASPER MARC N | Chairman & CEO | May 02 | Option Exercise | 129.77 | 10,000 | 1,297,700 | 193,373 | May 04 05:35 PM | Spar Debora L | Director | May 02 | Sale | 544.36 | 200 | 108,872 | 810 | May 04 05:45 PM | CASPER MARC N | Chairman & CEO | May 02 | Sale | 545.60 | 10,000 | 5,456,029 | 183,373 | May 04 05:35 PM | Lagarde Michel | Executive Vice President & COO | Mar 01 | Sale | 541.29 | 6,100 | 3,301,890 | 15,878 | Mar 02 04:17 PM | MANZI JIM P | Director | Feb 14 | Sale | 563.95 | 1,500 | 845,925 | 16,252 | Feb 15 08:24 PM | Stevenson Mark | Executive Vice President & COO | Dec 01 | Option Exercise | 175.46 | 26,925 | 4,724,374 | 86,181 | Dec 03 04:16 PM | Stevenson Mark | Executive Vice President & COO | Dec 01 | Sale | 631.88 | 26,925 | 17,013,310 | 59,256 | Dec 03 04:16 PM | Stevenson Mark | Executive Vice President & COO | Nov 02 | Option Exercise | 175.46 | 26,925 | 4,724,374 | 86,181 | Nov 03 04:36 PM | Williamson Stephen | Sr. VP and CFO | Nov 02 | Option Exercise | 129.77 | 22,550 | 2,926,314 | 62,771 | Nov 03 04:34 PM | Williamson Stephen | Sr. VP and CFO | Nov 02 | Sale | 638.10 | 22,550 | 14,389,045 | 40,221 | Nov 03 04:34 PM | Stevenson Mark | Executive Vice President & COO | Nov 02 | Sale | 638.03 | 26,925 | 17,179,054 | 59,256 | Nov 03 04:36 PM | Stevenson Mark | Executive Vice President & COO | Nov 01 | Option Exercise | 175.46 | 26,925 | 4,724,374 | 86,181 | Nov 03 04:36 PM | Stevenson Mark | Executive Vice President & COO | Nov 01 | Sale | 632.69 | 26,925 | 17,035,093 | 59,256 | Nov 03 04:36 PM |
|